Brown Rudnick has announced the appointment of Matthew Edwards as a new transactions partner within its global life sciences practice group based in London. Edwards, who brings extensive experience advising clients in the life sciences sector, has transitioned to Brown Rudnick from his previous role at Osborne Clarke.
In his new position, Edwards will focus on venture capital investments, mergers and acquisitions, joint ventures, initial public offerings (IPOs), and other securities-related issues. He is set to provide counsel to a range of clients, including companies at various developmental stages, investment funds, and investment banks active in the life sciences arena. This strategic hire underscores Brown Rudnick’s commitment to strengthening its offerings within the life sciences sector.
For more information, please read the full announcement from Brown Rudnick or view the original reporting by Bloomberg Law.